Skip to content
PubMed This is a summary of 67 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 67 referenced papers

Top Authors

Divyanshu Dubey
Mayo Clinic
Andrew McKeon
Mayo Clinic
Jérôme Honnorat
Lyon 1 Université
Eoin P. Flanagan
Mayo Clinic
Francesc Graus
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
Sarosh R. Irani
John Radcliffe Hospital
Alberto Vogrig
University of Udine
Sergio Muñiz‐Castrillo
Lyon 1 Université

Top Institutions

Ranked by publications Top 10 institutions

References

References (67)
  1. 1

    The Diagnosis and Treatment of Autoimmune Encephalitis.

    Lancaster E

    Journal of clinical neurology (Seoul, Korea) 2016; (12(1)):1-13 doi:10.3988/jcn.2016.12.1.1.

    PMID: 26754777
  2. 2

    A clinical approach to diagnosis of autoimmune encephalitis.

    Graus F, Titulaer MJ, Balu R, et al.

    The Lancet. Neurology 2016; (15(4)):391-404.

    PMID: 26906964
  3. 3

    Listeria rhombencephalitis mimicking a demyelinating event in an immunocompetent young patient.

    Décard BF, Thöne J, Haghikia A, et al.

    Multiple sclerosis (Houndmills, Basingstoke, England) 2017; (23(1)):123-125 doi:10.1177/1352458516650522.

    PMID: 27430683
  4. 4

    Anti-Ma and anti-Ma2-associated paraneoplastic neurological syndromes.

    Ortega Suero G, Sola-Valls N, Escudero D, et al.

    Neurologia 2018; (33(1)):18-27 doi:10.1016/j.nrl.2016.05.010.

    PMID: 27460184
  5. 5

    MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.

    Jarius S, Kleiter I, Ruprecht K, et al.

    Journal of neuroinflammation 2016; (13(1)):281 doi:10.1186/s12974-016-0719-z.

    PMID: 27802825
  6. 6

    ImmunoglobuliN in the Treatment of Encephalitis (IgNiTE): protocol for a multicentre randomised controlled trial.

    Iro MA, Sadarangani M, Absoud M, et al.

    BMJ open 2016; (6(11)):e012356 doi:10.1136/bmjopen-2016-012356.

    PMID: 27810972
  7. 7

    Treatment strategies for autoimmune encephalitis.

    Shin YW, Lee ST, Park KI, et al.

    Therapeutic advances in neurological disorders 2018; (11()):1756285617722347 doi:10.1177/1756285617722347.

    PMID: 29399043
  8. 8

    Clinical Presentation and Cranial MRI Findings of Listeria monocytogenes Encephalitis: A Literature Review of Case Series.

    Arslan F, Ertan G, Emecen AN, et al.

    The neurologist 2018; (23(6)):198-203 doi:10.1097/NRL.0000000000000212.

    PMID: 30379745
  9. 9

    Rapid detection of Listeria monocytogenes rhombencephalitis in an immunocompetent patient by multiplexed PCR.

    Richards RJ, Simon MS, Phillips CD, et al.

    BMJ case reports 2018; (2018()) doi:10.1136/bcr-2018-225575.

    PMID: 30413440
  10. 10

    Long-term Sequelae of Pediatric Bickerstaff Brainstem Encephalitis Includes Autonomic and Sleep Dysregulation.

    Santoro JD

    Journal of child neurology 2019; (34(3)):153-160 doi:10.1177/0883073818820488.

    PMID: 30604651
  11. 11

    Kelch-like Protein 11 Antibodies in Seminoma-Associated Paraneoplastic Encephalitis.

    Mandel-Brehm C, Dubey D, Kryzer TJ, et al.

    The New England journal of medicine 2019; (381(1)):47-54 doi:10.1056/NEJMoa1816721.

    PMID: 31269365
  12. 12

    Neurologic Autoimmunity in the Era of Checkpoint Inhibitor Cancer Immunotherapy.

    Zekeridou A, Lennon VA

    Mayo Clinic proceedings 2019; (94(9)):1865-1878 doi:10.1016/j.mayocp.2019.02.003.

    PMID: 31358366
  13. 13

    Brainstem Encephalitis With Low-Titer Acetylcholine Receptor Antibodies Mimicking Myasthenia Gravis.

    Ayzenberg I, Ellrichmann G, Schroeder C, et al.

    Frontiers in neurology 2019; (10()):829 doi:10.3389/fneur.2019.00829.

    PMID: 31428040
  14. 14

    F-Fluorodeoxyglucose positron-emission tomography for the investigation of malignancy in patients with suspected paraneoplastic neurologic syndromes and negative or indeterminate conventional imaging: a retrospective analysis of the Ontario PET Access Program, with systematic review and meta-analysis.

    Harlos C, Metser U, Poon R, et al.

    Current oncology (Toronto, Ont.) 2019; (26(4)):e458-e465 doi:10.3747/co.26.4583.

    PMID: 31548813
  15. 15

    Multiple co-existing antibodies in autoimmune encephalitis: A case and review of the literature.

    Kammeyer R, Piquet AL

    Journal of neuroimmunology 2019; (337()):577084 doi:10.1016/j.jneuroim.2019.577084.

    PMID: 31655424
  16. 16

    Differences and diversity of autoimmune encephalitis in 77 cases from a single tertiary care center.

    Saraya AW, Worachotsueptrakun K, Vutipongsatorn K, et al.

    BMC neurology 2019; (19(1)):273 doi:10.1186/s12883-019-1501-5.

    PMID: 31694559
  17. 17

    Epidemiology and Clinical Manifestations of Listeria monocytogenes Infection.

    Schlech WF

    Microbiology spectrum 2019; (7(3)) doi:10.1128/microbiolspec.GPP3-0014-2018.

    PMID: 31837132
  18. 18

    Paraneoplastic Diseases of the Central Nervous System.

    Galli J, Greenlee J

    F1000Research 2020; (9()) doi:10.12688/f1000research.21309.1.

    PMID: 32194943
  19. 19

    Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis.

    Dubey D, Wilson MR, Clarkson B, et al.

    JAMA neurology 2020; (77(11)):1420-1429 doi:10.1001/jamaneurol.2020.2231.

    PMID: 32744608
  20. 20

    Bickerstaff brainstem encephalitis with or without anti-GQ1b antibody.

    Yoshikawa K, Kuwahara M, Morikawa M, Kusunoki S

    Neurology(R) neuroimmunology & neuroinflammation 2020; (7(6)) doi:10.1212/NXI.0000000000000889.

    PMID: 32934014
  21. 21

    Paraneoplastic Myeloneuropathies: Clinical, Oncologic, and Serologic Accompaniments.

    Shah S, Vazquez Do Campo R, Kumar N, et al.

    Neurology 2021; (96(4)):e632-e639 doi:10.1212/WNL.0000000000011218.

    PMID: 33208548
  22. 22

    Rhombencephalitis due to Listeria monocytogenes infection with GQ1b antibody positivity and multiple intracranial hemorrhage: a case report and literature review.

    Zhao Y, Xu C, Tuo H, et al.

    The Journal of international medical research 2021; (49(4)):300060521998568 doi:10.1177/0300060521998568.

    PMID: 33866842
  23. 23

    Myelin Oligodendrocyte Glycoprotein (MOG)-IgG Associated Demyelinating Disease: Our Experience with this Distinct Syndrome.

    Pujari SS, Kulkarni RV, Nadgir DB, et al.

    Annals of Indian Academy of Neurology 2021; (24(1)):69-77 doi:10.4103/aian.AIAN_627_19.

    PMID: 33911382
  24. 24

    Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes.

    Blaes F

    Expert review of neurotherapeutics 2021; (21(6)):675-686 doi:10.1080/14737175.2021.1927713.

    PMID: 33960258
  25. 25

    Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes.

    Graus F, Vogrig A, Muñiz-Castrillo S, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2021; (8(4)) doi:10.1212/NXI.0000000000001014.

    PMID: 34006622
  26. 26

    Antibody-Mediated Autoimmune Diseases of the CNS: Challenges and Approaches to Diagnosis and Management.

    Sechi E, Flanagan EP

    Frontiers in neurology 2021; (12()):673339 doi:10.3389/fneur.2021.673339.

    PMID: 34305787
  27. 27

    Paraneoplastic neurological syndromes: a practical approach to diagnosis and management.

    Binks S, Uy C, Honnorat J, Irani SR

    Practical neurology 2022; (22(1)):19-31 doi:10.1136/practneurol-2021-003073.

    PMID: 34510016
  28. 28

    Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis.

    Vogrig A, Péricart S, Pinto AL, et al.

    Brain communications 2021; (3(3)):fcab185 doi:10.1093/braincomms/fcab185.

    PMID: 34557666
  29. 29

    Breast cancer-associated opsoclonus-myoclonus syndrome: a case report.

    Kostoglou A, Vlastos D, Bakalis A, Ghosh D

    World journal of surgical oncology 2021; (19(1)):328 doi:10.1186/s12957-021-02436-7.

    PMID: 34781971
  30. 30

    Immunotherapy for Refractory Autoimmune Encephalitis.

    Yang J, Liu X

    Frontiers in immunology 2021; (12()):790962 doi:10.3389/fimmu.2021.790962.

    PMID: 34975890
  31. 31

    Additional Value of [18F]FDG PET/CT in Detection of Suspected Malignancy in Patients with Paraneoplastic Neurological Syndromes Having Negative Results of Conventional Radiological Imaging.

    Opalińska M, Sowa-Staszczak A, Wężyk K, et al.

    Journal of clinical medicine 2022; (11(6)) doi:10.3390/jcm11061537.

    PMID: 35329862
  32. 32

    Detection and significance of neuronal autoantibodies in patients with meningoencephalitis in Vientiane, Lao PDR.

    Uy CE, Mayxay M, Harrison R, et al.

    Transactions of the Royal Society of Tropical Medicine and Hygiene 2022; (116(10)):959-965 doi:10.1093/trstmh/trac023.

    PMID: 35385878
  33. 33

    Modified Zipper Method, a Promising Treatment Option in Severe Pediatric Immune-Mediated Neurologic Disorders.

    Nikolaus M, Kühne F, Tietze A, et al.

    Journal of child neurology 2022; (37(6)):505-516 doi:10.1177/08830738221089476.

    PMID: 35435761
  34. 34

    Clinical Reasoning: A 43-Year-Old Man With Subacute Onset of Vision Disturbances, Jaw Spasms, and Balance and Sleep Difficulties.

    Orozco E, Guo Y, Chen JJ, et al.

    Neurology 2022; (99(9)):387-392 doi:10.1212/WNL.0000000000200950.

    PMID: 35794020
  35. 35

    Weakness in both lower limbs for 1 week and blepharoptosis for 3 days in a boy aged 1 year and 7 months.

    Lang CH, Tian MQ, Shu XM

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2022; (24(8)):923-927 doi:10.7499/j.issn.1008-8830.2203101.

    PMID: 36036132
  36. 36

    MOG antibody-associated encephalitis in adult: clinical phenotypes and outcomes.

    Lee WJ, Kwon YN, Kim B, et al.

    Journal of neurology, neurosurgery, and psychiatry 2023; (94(2)):102-112 doi:10.1136/jnnp-2022-330074.

    PMID: 36261287
  37. 37

    Autoimmune encephalitis : Part 1 (Epidemiology, Pathophysiology and Clinical spectrum).

    Hiesgen J, Schutte C

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2023; (113(3)):116-121 doi:10.7196/SAMJ.2023.v113i3.780.

    PMID: 36876355
  38. 38

    Characterization and prognosis of autoimmune encephalitis in the neurological intensive care unit: a retrospective study.

    Qin N, Wang J, Wu X, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2023; (44(8)):2889-2895 doi:10.1007/s10072-023-06778-w.

    PMID: 36977957
  39. 39

    Listeria rhombencephalitis mimicking stroke in a patient with giant cell arteritis.

    Shimizu H, Imoto H, Hara S, Nishioka H

    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2023; (29(7)):703-706 doi:10.1016/j.jiac.2023.03.016.

    PMID: 36996936
  40. 40

    Autoimmune Encephalitis Criteria in Clinical Practice.

    Orozco E, Valencia-Sanchez C, Britton J, et al.

    Neurology. Clinical practice 2023; (13(3)):e200151 doi:10.1212/CPJ.0000000000200151.

    PMID: 37124463
  41. 41

    Epidemiology, clinical and imaging features of rhombencephalitis caused by L. monocytogenes. A retrospective observational study.

    Láinez-Ramos Bossini AJ, Redruello-Guerrero P, Martínez-Barbero JP, et al.

    Revista de neurologia 2023; (76(12)):385-390 doi:10.33588/rn.7612.2023020.

    PMID: 37303100
  42. 42

    Paraneoplastic encephalitis: clinically based approach on diagnosis and management.

    Vaišvilas M, Ciano-Petersen NL, Macarena Villagrán-García MD, et al.

    Postgraduate medical journal 2023; (99(1173)):669-678 doi:10.1136/postgradmedj-2022-141766.

    PMID: 37389581
  43. 43

    General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis.

    Masciocchi S, Businaro P, Scaranzin S, et al.

    Critical reviews in clinical laboratory sciences 2024; (61(1)):45-69 doi:10.1080/10408363.2023.2247482.

    PMID: 37777038
  44. 44

    Revisiting anti-Hu paraneoplastic autoimmunity: phenotypic characterization and cancer diagnosis.

    Villagrán-García M, Farina A, Muñiz-Castrillo S, et al.

    Brain communications 2023; (5(5)):fcad247 doi:10.1093/braincomms/fcad247.

    PMID: 37794924
  45. 45

    Outcome and Sequelae of Autoimmune Encephalitis.

    Kvam KA, Stahl JP, Chow FC, et al.

    Journal of clinical neurology (Seoul, Korea) 2024; (20(1)):3-22 doi:10.3988/jcn.2023.0242.

    PMID: 38179628
  46. 46

    Pearls & Oy-sters: KLHL11 IgG Paraneoplastic-Associated Hearing Loss and Rhombencephalitis in a Woman With Metastatic Müllerian Tumor.

    Agyei P, Chen M, Guo Y, et al.

    Neurology 2024; (102(7)):e209187 doi:10.1212/WNL.0000000000209187.

    PMID: 38484225
  47. 47

    Clinical approach to diagnosis of paraneoplastic neurologic syndromes.

    Graus F

    Handbook of clinical neurology 2024; (200()):79-96 doi:10.1016/B978-0-12-823912-4.00007-4.

    PMID: 38494298
  48. 48

    Expanding Clinical Spectrum of Anti-GQ1b Antibody Syndrome: A Review.

    Lee SU, Kim HJ, Choi JY, et al.

    JAMA neurology 2024; (81(7)):762-770 doi:10.1001/jamaneurol.2024.1123.

    PMID: 38739407
  49. 49

    Paraneoplastic Neurologic Disorders.

    Zekeridou A

    Continuum (Minneapolis, Minn.) 2024; (30(4)):1021-1051 doi:10.1212/CON.0000000000001449.

    PMID: 39088287
  50. 50

    Analysis of a case report of meningitis caused by Listeria monocytogenes.

    Chen L, Pei M, Wang X, et al.

    Frontiers in medicine 2024; (11()):1440225 doi:10.3389/fmed.2024.1440225.

    PMID: 39323466
  51. 51

    Pediatric MOG-Ab-Associated Encephalitis: Supporting Early Recognition and Treatment.

    Kim NN, Champsas D, Eyre M, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2024; (11(6)):e200323 doi:10.1212/NXI.0000000000200323.

    PMID: 39393046
  52. 52

    First case report on Bickerstaff brainstem encephalitis in a young adult from Syria: Bridging clinical knowledge and practice.

    Almohamed A, Qatza A, Alsamman H, et al.

    Radiology case reports 2025; (20(2)):1211-1214 doi:10.1016/j.radcr.2024.11.006.

    PMID: 39697258
  53. 53

    Autoimmune brainstem encephalitis: Clinical associations, outcomes, and proposed diagnostic criteria.

    Gilligan M, Thakolwiboon S, Orozco E, et al.

    Annals of clinical and translational neurology 2025; (12(1)):213-225 doi:10.1002/acn3.52273.

    PMID: 39708293
  54. 54

    Bickerstaff brainstem encephalitis-Miller-Fisher syndrome (BBE-MFS) overlap with negative anti-GQ1b serology.

    Nayak M V, Sharma H, Nagaraju S, Prabhu MM

    BMJ case reports 2024; (17(12)) doi:10.1136/bcr-2024-261975.

    PMID: 39950622
  55. 55

    Systemic lupus erythematosus with hypothermia and Wallenberg's syndrome as signs of brainstem encephalitis: A grand rounds case.

    Shiratani R, Shibahara T, Shiba M, et al.

    Lupus 2025; (34(5)):525-532 doi:10.1177/09612033251324496.

    PMID: 40010374
  56. 56

    Paraneoplastic cerebellitis with Kelch-like protein 11 antibodies as an initial presentation for testicular seminoma.

    Mercer JS, Myers E, Labriola MK

    BMJ case reports 2025; (18(8)) doi:10.1136/bcr-2024-262710.

    PMID: 40759499
  57. 57

    Anti-GQ1b Antibody Syndrome: A Clinician-Oriented Perspective on Diagnostics, Therapy, and Atypical Phenotypes-With an Illustrative 16-Case Institutional Series.

    Bannai T, Yamada M, Seki T, et al.

    Journal of clinical medicine 2026; (15(2)) doi:10.3390/jcm15020801.

    PMID: 41598737
  58. 58

    Brainstem Encephalitis in Neuropsychiatric Systemic Lupus Erythematosus Mimicking Malignant Lymphoma: A Case Report and Literature Review.

    Ueno T, Ochiai S

    Cureus 2026; (18(1)):e101551 doi:10.7759/cureus.101551.

    PMID: 41694957
  59. 59

    Severe sleep-related hypoventilation in antibody-positive and antibody-negative autoimmune encephalitis: an emergency.

    Jeantin L, Gales A, Psimaras D, et al.

    The European respiratory journal 2026; (67(6)) doi:10.1183/13993003.01848-2025.

    PMID: 41786496
  60. 60

    Clinical features of paraneoplastic neurologic syndromes with anti-Ri antibodies: PRISMA systematic review.

    Chen Y, Wu C, Liu X, et al.

    Journal of neurology 2026; (273(4)).

    PMID: 41894019
  61. 61

    A unified spectrum model for the anti-GQ1b antibody syndromes: from pathophysiology to a new diagnostic framework.

    El Abdi K, Bibi F, Ibrahim M, et al.

    Frontiers in neurology 2026; (17()):1763283 doi:10.3389/fneur.2026.1763283.

    PMID: 42093930
  62. 62

    Clinical Manifestations, Tumor Associations, and Long-Term Outcomes of Anti-KLHL11 Encephalitis.

    Jin M, Brand T, Erdag Turgeon E, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2026; (13(4)):e200597 doi:10.1212/NXI.0000000000200597.

    PMID: 42214057
  63. 63

    Unmasking Probable Bickerstaff Brainstem Encephalitis in the Absence of Radiological and Cerebrospinal Fluid Clues.

    Paul S, Srinivasan D, Pandurangan V

    Cureus 2026; (18(5)):e109352 doi:10.7759/cureus.109352.

    PMID: 42326191
  64. 64

    [Meningoencephalitis caused by listeria monocytogenes].

    Franke I, Strahm C, Lauber A, Lienert C

    Praxis 2026; (115(6)):176-179 doi:10.23785/PRAXIS.2026.06.006.

    PMID: 42346978
  65. 65

    Listerial rhombencephalitis diagnosed by repeat blood culture despite negative CSF PCR: a case report.

    Arientová S, Galušková R, Ceprová L, et al.

    ASM case reports 2026; (2(5)) doi:10.1128/asmcr.00063-26.

    PMID: 42683398
  66. 66

    Neuroimmune mechanisms of the cerebellum-brainstem network in autoimmune encephalitis and related neuroimmune disorders: antibody targets, selective vulnerability, and translational opportunities.

    Li Y, Hu Y, Yang Y, et al.

    Frontiers in immunology 2026; (17()):1909595 doi:10.3389/fimmu.2026.1909595.

    PMID: 42713200
  67. 67

    Dropped head syndrome as the sole presenting manifestation of probable post-cytomegalovirus immune-mediated brainstem encephalitis in an immunocompetent woman: a case report.

    Zhou B, Song Z, Bi N, et al.

    Frontiers in immunology 2026; (17()):1861881 doi:10.3389/fimmu.2026.1861881.

    PMID: 42729421